Mucinex Childrens Freefrom Multi-Symptom Cold and Stuffy Nose

Description

This formulation contains Dextromethorphan HBr, a cough suppressant; Guaifenesin, an expectorant; and Phenylephrine HCl, a nasal decongestant. It is free from artificial flavors, colors, and dyes, as well as alcohol and sugar. The product features natural honey and berry flavoring. It is suitable for individuals aged 4 years and older and is provided in a dosage form of 4 fluid ounces (118 mL).

Uses and Indications

This drug is indicated for the relief of cough associated with minor throat and bronchial irritation, which may occur due to the common cold or inhaled irritants. It assists in loosening phlegm (mucus) and thinning bronchial secretions, thereby facilitating the clearance of mucus from the bronchial passageways and making coughs more productive.

Additionally, this drug temporarily relieves the intensity of coughing and the impulse to cough, which may help children achieve restful sleep. It also alleviates nasal congestion and a stuffy nose associated with colds.

There are no teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

The maximum recommended dosage is six doses within a 24-hour period. Dosing should be measured exclusively with the dosing cup provided, and this cup should not be used for other products to ensure accurate measurement.

For children aged 6 to under 12 years, the recommended dose is 10 mL every 4 hours as needed. For children aged 4 to under 6 years, the appropriate dose is 5 mL every 4 hours as needed. It is important to note that this product is not recommended for use in children under 4 years of age.

Healthcare professionals should advise caregivers to adhere strictly to these dosing guidelines or any alternative dosing instructions provided by a physician.

Contraindications

Use of this product is contraindicated in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing an MAOI. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, and Parkinson's disease. If there is uncertainty regarding the presence of an MAOI in a child's prescription, consultation with a healthcare professional is advised prior to administration of this product. Additionally, it is contraindicated to exceed the recommended dosage while using this product.

Warnings and Precautions

It is imperative to adhere to the following warnings and precautions when administering this product to ensure the safety and well-being of pediatric patients.

Contraindications This product must not be used in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing such medication. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease. If there is uncertainty regarding the presence of an MAOI in a child's prescription, consultation with a healthcare professional, such as a doctor or pharmacist, is essential prior to administration.

Pre-existing Conditions Prior to use, it is crucial to consult a healthcare provider if the child has any of the following conditions:

• Heart disease

• High blood pressure

• Thyroid disease

• Diabetes

• Persistent or chronic cough, particularly associated with asthma

• Cough accompanied by excessive phlegm (mucus)

Dosage and Administration When utilizing this product, it is vital to adhere strictly to the recommended dosage. Exceeding the directed amount can lead to adverse effects.

Monitoring and Discontinuation Healthcare professionals should advise caregivers to discontinue use and seek medical advice if any of the following occur:

• Nervousness, dizziness, or sleeplessness

• Symptoms that do not improve within 7 days or are accompanied by fever

• A cough that persists beyond 7 days, recurs, or is associated with fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

Safety Precautions This product should be kept out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days, or if they occur alongside fever, medical advice should be sought. A cough that persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache may indicate a serious condition and warrants immediate medical attention.

Drug Interactions

The concomitant use of this product with monoamine oxidase inhibitors (MAOIs) is contraindicated in pediatric patients. MAOIs are typically prescribed for the treatment of depression, psychiatric disorders, emotional conditions, or Parkinson's disease. Administration of this product should be avoided in children who are currently taking an MAOI or within 14 days of discontinuing such therapy.

Healthcare professionals are advised to confirm whether a child's prescription includes an MAOI prior to the initiation of this product. If there is any uncertainty regarding the presence of an MAOI in the child's medication regimen, consultation with a physician or pharmacist is strongly recommended to ensure patient safety.

Packaging & NDC

Below are the non-prescription pack sizes of Mucinex Childrens Freefrom Multi-Symptom Cold and Stuffy Nose (dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 4 years and older may use this product, with specific dosing guidelines based on age. For children aged 6 to under 12 years, the recommended dose is 10 mL every 4 hours, while for those aged 4 to under 6 years, the dose is 5 mL every 4 hours. It is important to note that this product should not be used in children under 4 years of age.

Healthcare professionals should advise caregivers to avoid using this product in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of stopping an MAOI. Prior to use, it is essential to consult a doctor if the child has any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as occurs with asthma), or cough associated with excessive phlegm.

Caregivers must adhere to the dosing instructions and should not exceed 6 doses in any 24-hour period. The dosing cup provided should be used exclusively for this product, and not with other medications. If symptoms do not improve within 7 days, or if they are accompanied by fever, or if the cough persists for more than 7 days, recurs, or occurs with fever, rash, or persistent headache, caregivers should discontinue use and consult a doctor.

Nervousness, dizziness, or sleeplessness are potential side effects that warrant stopping the use of the product and seeking medical advice. It is crucial to keep this product out of reach of children, and in the event of an overdose, immediate medical assistance or contact with a Poison Control Center is necessary.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional prior to use, as there may be potential risks to the fetus. Specific studies or data regarding fetal outcomes are not provided in the prescribing information. No dosage modifications for pregnant individuals are mentioned; however, it is strongly advised that medical advice be sought before using this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution and consider the overall clinical context when prescribing this medication to patients with hepatic impairment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be aware that the specific symptoms of an overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential to determine the appropriate course of action.

Management of an overdose typically involves supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and clinical status is recommended. In cases where the specific substance is known, targeted therapies may be employed as indicated.

It is essential for healthcare providers to remain vigilant and act swiftly in the management of overdose situations to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Individuals are encouraged to report any adverse events to the designated phone number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

It is crucial to inform patients that this product should not be used in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within two weeks of stopping such medication. Patients should be encouraged to consult with a doctor or pharmacist if they are uncertain whether their child's prescription includes an MAOI.

Patients should be instructed to discontinue use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, they should seek medical advice if symptoms do not improve within seven days, or if they occur alongside fever. Patients should also be made aware that a cough lasting more than seven days, recurring cough, or cough accompanied by fever, rash, or persistent headache may indicate a serious condition and warrants medical evaluation.

While using this product, patients must be reminded not to exceed the recommended dosage. Furthermore, healthcare providers should encourage patients to consult a doctor before use if the child has any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as that associated with asthma), or a cough that produces excessive phlegm (mucus).

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 20-25°C (68-77°F). Refrigeration is not recommended, as the product should not be exposed to lower temperatures. Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Mucinex Childrens Freefrom Multi-Symptom Cold and Stuffy Nose, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)